| Names | |
|---|---|
| Preferred IUPAC name | 1-methyl-2-(2-chlorophenyl)-4,5-dihydro-3H-pyrazol-3-one |
| Other names | 2-Chloroantipyrine 2-Chloro-1-phenyl-3-methyl-5-pyrazolone |
| Pronunciation | /waɪn-tuː-klɔːrəˈfiːnɪl θriː-ˈmɛθɪl faɪ-paɪˈræzəˌloʊn/ |
| Identifiers | |
| CAS Number | 85-98-3 |
| Beilstein Reference | 72998 |
| ChEBI | CHEBI:76466 |
| ChEMBL | CHEMBL157355 |
| ChemSpider | 398682 |
| DrugBank | DB01023 |
| ECHA InfoCard | 20b3c995-7e34-4c26-9635-8b0d24dd47ce |
| Gmelin Reference | Gmelin 83654 |
| KEGG | C14231 |
| MeSH | D015242 |
| PubChem CID | 3682 |
| RTECS number | CM5075000 |
| UNII | CBJ1YO27EN |
| UN number | UN2811 |
| CompTox Dashboard (EPA) | DTXSID3020682 |
| Properties | |
| Chemical formula | C10H9ClN2O |
| Molar mass | 211.65 g/mol |
| Appearance | white to light yellow crystalline powder |
| Odor | Odorless |
| Density | 1.27 g/cm³ |
| Solubility in water | slightly soluble |
| log P | 1.83 |
| Vapor pressure | 0.0000825 mmHg at 25°C |
| Acidity (pKa) | 4.27 |
| Basicity (pKb) | 7.52 |
| Magnetic susceptibility (χ) | -56.44 × 10⁻⁶ cm³/mol |
| Refractive index (nD) | 1.603 |
| Viscosity | Viscous liquid |
| Dipole moment | 3.73 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 317.6 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -63.0 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | -362.8 kJ/mol |
| Pharmacology | |
| ATC code | N02BB02 |
| Hazards | |
| Main hazards | Harmful if swallowed. Causes skin irritation. Causes serious eye irritation. May cause respiratory irritation. |
| GHS labelling | GHS02, GHS07 |
| Pictograms | GHS07 |
| Signal word | Warning |
| Hazard statements | H302, H315, H319, H335 |
| Precautionary statements | P280, P305+P351+P338, P337+P313 |
| NFPA 704 (fire diamond) | 1-2-0 |
| Flash point | 93.3 °C |
| Lethal dose or concentration | LD50 oral rat 335 mg/kg |
| LD50 (median dose) | LD50 (rat, oral): 2650 mg/kg |
| NIOSH | SN1575000 |
| PEL (Permissible) | Not established |
| REL (Recommended) | 0.02 mg/m³ |
| Related compounds | |
| Related compounds | Antipyrine 4-Aminoantipyrine Dipyrone Ramifenazone |
| Category | Description |
|---|---|
| Product Name & IUPAC Name |
IUPAC: 1-(2-chlorophenyl)-3-methyl-1H-pyrazol-5(4H)-one Common Name: 1-(2-Chlorophenyl)-3-methyl-5-pyrazolone |
| Chemical Formula | C10H9ClN2O |
| Synonyms & Trade Names |
2-Chlorophenyl methyl pyrazolone 1-(o-Chlorophenyl)-3-methyl-5-pyrazolone |
| HS Code & Customs Classification |
HS Code: Classified according to chemical structure under aromatic heterocyclic compounds, typically under chapter 2933 of international customs regulations. Exact code selection may depend on the presence of other substituents and national customs interpretations of the heterocycle subclass. |
In the production department, we see batch-to-batch consistency in molecular integrity as central for downstream pharmaceutical intermediates or specialty pigment precursors. The raw material grade selection for 2-chloroaniline and acetylacetone directly shapes both yield and side product spectrum. Variability in starting material purity leads to changes in impurity profiles—especially halogenated byproducts and N-alkylated analogs, which remain a key in-process control focus point.
Manufacturers navigating pyrazolone synthesis routes often optimize reaction pH and temperature to limit byproduct formation and maximize process economy. Impurity carryover, especially for halogenated side chains, requires deliberate isolation and purification steps. Final product grade, moisture content, and trace impurity control are tailored by application: pharmaceuticals will demand additional chromatographic or recrystallization steps that would not apply to pigment or technical grades.
Release standards for each shipment reflect requirements negotiated per customer specification as well as internal protocols. These protocols include detailed analysis of related substances and residual solvents, which differ by intended use and market region. Packaging and transport classification follow regulatory expectations for aromatic heterocycles; product shelf life claims are supported only where stability studies have been completed on representative batches.
Raw material traceability and thorough documentation support compliance with REACH or other jurisdictional handling codes. These factors combine to give process engineers and quality teams concrete data for risk assessment—not just formulaic quality boilerplate.
Production runs of 1-(2-Chlorophenyl)-3-methyl-5-pyrazolone generally yield a crystalline solid, with color ranging from off-white to light yellow, depending on grade and purification history. The odor profile tends to be faint or neutral if free of volatile impurities. Melting and boiling point values shift according to impurity level and residual solvent, so QA labs determine batch-specific reports for release documentation. Density is influenced by particle size and compaction during downstream drying or pelletizing.
Careful exclusion of moisture and strong oxidants prevents degradation during storage and transport. The molecule’s aromatic-chloride function resists most base and weak acid hydrolysis, but high-temperature contact with alkali can generate side products. Process residues from synthesis—especially residual base or metal traces—heighten risk of color formation or decomposition on exposure to heat and light.
Solubility profiles are grade-dependent. Lower impurity, higher-purity grades dissolve smoothly in polar organic solvents such as ethanol and acetone; technical grades may show cloudiness or insoluble residues. Solid solution preparation requires slow addition and stirring at moderate temperature to prevent agglomeration or localized concentration spikes, which can affect formulation end-use.
Product specifications differ substantially for research, pharmaceutical-intermediate, and industrial grades. Key parameters include appearance, assay by HPLC, loss on drying, and residue on ignition. For custom grades, particle size and bulk density may also be specified. The final release standard is set according to internal production protocol and client requirements where applicable.
| Property | Industrial Grade | Pharma-Intermediate | Test Method |
|---|---|---|---|
| Assay (HPLC/GC) | Typical lower bound* | Higher lower bound* | Validated Method |
| Appearance | Cream to yellow crystal | Off-white crystal | Visual |
| Impurities (Total) | Process-specific* | Tighter limit* | HPLC |
| Moisture Content | Controlled within range* | Lower maximum* | Loss on Drying |
*Typical values depend on batch, synthesis route, and customer specification.
Profiled impurities stem from incomplete cyclization, side-chain isomerization, and chlorination byproducts during synthesis. Impurity limits follow usage context—API precursor batches undergo tighter scrutiny than technical batches intended for colorant intermediates. Process optimization narrows impurity spread; QA releases depend on HPLC, GC, and in some applications, NMR analysis.
In-house analytical methods support every batch, validated against industry practice. Reference standards must match synthesis route when reporting trace impurities, as byproduct range shifts with solvent and catalyst regime. Client or third-party method validation may supplement routine analysis for regulated applications.
Selection of 2-chloroacetophenone and suitable methylhydrazine input guides both yield and byproduct spectrum. Origin and purity of starting materials sway long-run consistency, especially in pharmaceutical intermediate manufacture. Reliable vendor qualification and testing protects batch reproducibility from upstream variations.
The typical route involves a condensation-cyclization between 2-chloroacetophenone and methylhydrazine under controlled conditions, forming the pyrazolone core. Side reactions stem from reagent excess or local overheating, leading to either over-chlorination or undesired ring cleavage. Route selection aligns with both safety constraints and downstream purity targets.
Temperature stability, pH regulation, and addition rate are central to consistent conversion and selectivity. Solvent extraction and multistage recrystallization remove soluble and insoluble impurities. Filtration, drying, and, if required, micronization steps follow. Each production cycle is monitored for critical parameters by continuous sampling or at set in-process checkpoints.
QC labs check final bulk lots against release criteria for identity, purity, and critical impurity content. Batch records document all process deviations, in-line corrections, and cleaning validation. Release relies on certificate of analysis, with retesting protocols for aged stock or deviations from standard packaging or storage.
The pyrazolone nucleus allows for alkylation, acylation, and N-arylation, making it central as an intermediate for pharmaceutical and dye molecules. The ortho-chloro substituent enables further electrophilic substitution under controlled conditions, expanding modification routes.
Choice of solvent, catalyst, and temperature depends on target transformation—alkylations require non-nucleophilic bases and moderate heat; acylation or coupling reactions match to higher-purity grades. Metal catalysts or acid promoters see use in more demanding downstream functionalization, but risk coloration if not rigorously removed post-reaction.
Derivative production leans on clean 1-(2-chlorophenyl)-3-methyl-5-pyrazolone. Any remnant of starting hydrazine, or process solvents, risks interference or batch rejection in higher-added-value synthesis chains, such as APIs or specialty colorants.
Warehouse lots require cool, dry, and dark conditions to minimize hydrolysis or discoloration. Absence of humidity and heat gradients reduces risk of caking, clumping, or low-level decomposition. Some grades packed under inert gas extend shelf life for sensitive end uses.
Solid pyrazolone grades store safely in HDPE drums, multi-layered sacks, or lined fiberboard containers. For highly-purified or moisture-sensitive stock, lined metal kegs carry an extra barrier against vapor ingress. Packaging selection matches both product grade and logistics handling risk.
Shelf life depends on impurity content, packaging integrity, and storage environment. Batches should be monitored for color change, odor release, or caking, all indicating possible degradation. Retesting is scheduled for aging lots prior to any critical downstream use.
Hazard classification is dictated by batch impurity profile and regional regulations. Causes skin and eye irritation in direct contact; toxicity data vary with process residues. Dust or aerosol formation in production or downstream blending requires local exhaust ventilation and containment.
Process engineers direct workers to avoid skin, eye, and respiratory exposure using standard PPE—chemical-resistant gloves, goggles, and fitted respirators when dusting risk exists. No open food, drink, or smoking in production areas. Spills must be contained and cleaned by wet sweeping or compliant vacuum.
Experimental toxicity data reference published literature where available; production facilities conduct routine occupational exposure monitoring. Absorption through skin is possible with high exposure; acute exposure limits depend on residual hydrazine level and trace solvents. Chronic effects relate more to handling frequency and personal protective practice than to the finished product under controlled use.
Workplace exposure controls rely on solid containment, ventilated transfer, and closed-system dispensing for larger-scale operations. All waste and wash-down are handled via on-site effluent treatment facilities, documented under site environmental plan.
Typical production output for 1-(2-Chlorophenyl)-3-methyl-5-pyrazolone varies with installed reactor scale, campaign allocation, feedstock schedules, and grade breakdown. For pharmaceutical/intermediate grades, production batches often depend on forward orders, ongoing campaigns, and QA release timing. Overbooking pressures can build during regulatory inspection windows or process changeovers as plants switch between multi-purpose syntheses. Unplanned downtime in upstream chlorination or pyrazolone coupling may limit short-term availability. Process chemistry for this molecule has a moderate degree of exothermic reaction hazard, especially during chlorophenyl intermediate handling, which shapes batch size and sequencing.
Commercial availability depends on inventory rotation and campaign cycle. Availability fluctuates for dedicated high-purity grades; standard technical grade may see steadier volumes but can inherit queue delays if upstream intermediates are diverted for higher-margin campaigns.
Regular supply orders can factor in lead times of 2-6 weeks, but this varies by campaign cycle and region. MOQ is typically driven by batch processing scale, downstream purification requirements, and shipping container logistics. Higher grades or custom purities may come with higher MOQ depending on customer file, regulatory documentation, and purification cost structure.
Packaging choices focus on moisture control and contamination risk mitigation. Common formats include fiber drums with poly liners, HDPE containers for sample lots, or steel drums for export, each internally validated based on reactivity profile and customer requirements for traceability. Larger lots for polymer or agrochemical use may ship in isotanks or bulk bags, but tonnage orders will depend on dedicated tank space and compatibility.
Shipping terms are negotiated per region and customer logistics—most routes leverage sea freight for regular volumes, with temperature and light exposure parameters specified for higher grade shipments. Payment terms reflect customer track record, with standard options running from advance remittance to net 30/60, subject to credit evaluation.
Production cost structure begins with the chlorinated aromatic starting material and extends through coupling reagents and energy use in solvent recovery. Raw material price swings trace back to volatility in chlorobenzene, methylhydrazine, and solvent blends, each with upstream dependency on energy and commodity chemical cycles. Some costs reflect process yield and purification efficiency, especially with high-purity grades where additional distillation or crystallization stages are needed to meet impurity release specs.
Feedstock and energy volatility remain the primary drivers of raw material cost swings. Regulatory actions on chlorinated aromatic import/export quotas, environmental surcharges on process waste (especially in East Asia and India), and logistical bottlenecks at major ports also feed into short-term cost spikes.
Price for 1-(2-Chlorophenyl)-3-methyl-5-pyrazolone differentiates sharply based on three axes: grade, purity, and packaging. Higher purities (<99%) command premium pricing due to additional QA/QC release steps and custom documentation. Certification needs (such as GMP traceability or full CoA/DOSSIER support) raise costs by increasing batch segregation, documentation, and dedicated line usage. Packaging with validated inert liners or customized traceability tags may also reflect in price differentials.
Key production clusters center in East China and Western India, with smaller volumes from Japan and emerging capacity in Eastern Europe. Aggregate demand remains stable in pharmaceuticals and agrochemicals, while application-specific spikes often depend on regulatory approval cycles and end-of-life patent dynamics for pharmaceuticals incorporating this intermediate.
| Region | Drivers | Constraints |
|---|---|---|
| US | Stable downstream use, consistent regulatory environment. | Tariffs, import COCs may slow sourcing of key intermediates. |
| EU | Demand shaped by pharma sector, REACH compliance drives batch lot traceability. | CLP labeling updates and site registration review can disrupt flow. |
| JP | Emphasis on ultra-high purity and process validation restrains demand volatility. | Local producers favored, while importers need supplementary QC data. |
| IN | Competitive labor and process costs underpin price levels. | Environmental surcharges and sudden regulatory shifts cause short-term supply variance. |
| CN | Largest production base, rapid scale flex for technical grades. | Pollution crackdowns, energy rationing increase seasonal volatility. |
Based on current energy market conditions, anticipated capacity announcements, and regulatory cycles, cost pressure will remain for high-grade product as process waste compliance and purification requirements escalate. Lower grade/material use may benefit from process intensification and raw material chain integration in China and India, barring major export policy changes. General consensus in late 2023 points to high single-digit percentage price shifts for pharma-grade lots, while technical grade pricing will respond more closely to commodity feedstock trends. Uncertainties include the impact of new waste management fees and upstream chlorination process directives in China.
Price assessment references: benchmark quotes from feedstock producers (chlorobenzene, methylhydrazine), import/export registration filings (CN/EU/IN jurisdiction reports), and published chemical market bulletins. Forecasts rely on plant visit data, customer offtake schedules, and regional energy tariff outlooks.
Inspection cycles for key intermediates in major manufacturing parks in China pushed some capacity offline in Q4 2023. Several Indian facilities adopted new in-line effluent monitoring, raising operational costs for technical grade production. Import/export regulatory harmonization between EU and UK reached a milestone in 2024, smoothing documentation for REACH/PIC compliance but still requiring separate batch releases per jurisdiction.
Chlorinated aromatic intermediates continue to attract attention in updated schedules of the Stockholm and Rotterdam Conventions, affecting long-term capacity expansion, particularly in China and India. New guidance in the EU regarding impurity profile reporting for pharmaceutical intermediates may trigger further changes to analytical release protocols and data retention periods. Compliance requirements now intersect more tightly with lot tracking and electronic batch reporting.
Manufacturers have accelerated process analytics, batch release digitization, and investment in on-site waste handling infrastructure. Production scheduling now incorporates scenario planning for regional power curtailments and upstream raw material disruptions. Close coordination with major downstream customers helps prioritize campaign timing and mitigate potential shortages. Release criteria tightening in response to evolving regulatory standards draws on in-process monitoring and fast QA turnaround capacity.
1-(2-Chlorophenyl)-3-methyl-5-pyrazolone typically enters production lines in dyestuff synthesis, pharmaceutical intermediates, laboratory reagents, and specialty materials R&D. In colorant manufacture, this intermediate supports the formation of pigment architectures requiring a substituted pyrazolone ring. In pharma processing, our material commonly features as a building block in non-steroidal anti-inflammatory drug synthesis pathways or related research. Small-scale specialty chemical production may also source technical grades for structure-activity exploration or analytically driven compound libraries.
| End Use | Preferred Grade Tier | Critical Parameters |
|---|---|---|
| Dyestuffs & Pigments | Technical, Industrial | Assay/purity profile; color index; process contaminants |
| Pharmaceutical Synthesis | Pharma, High-Purity | Specified purity, known impurity spectrum, residual solvents |
| Analytical Reagents | Analytical, Research | Batch reproducibility, documented analytical traceability |
| Specialty R&D | Custom, Project-based | Specification by agreement; customized impurity management |
Colorant & Pigment Use: Industrial buyers for pigment synthesis focus on robust color performance and minimal interference from side-products, typically asking for transparency on the impurity load and practical solubility in target reaction media. Variations in trace organics can shift downstream shade or batch-to-batch consistency.
Pharmaceutical Use: Drug precursor supply to pharma clients steers raw material handling towards documented impurity profiles and solvent residual control. The impurity content must match pharmacopeia or customer-defined limits, with release based on validated in-house or accredited third-party test methods.
Analytical or Custom Synthesis: R&D and reference-grade users often contractually define both assay requirements and maximum allowable contaminants. Batch control concentrates around reproducibility, and documentation support for traceability and chain-of-custody becomes central.
The pragmatic way forward begins by clearly identifying the material's final use. Production batches intended for high-throughput pigments will not align with purity standards set for medicinal chemistry. Application specifics such as regulatory endpoints, required functionality, and volume requirements determine grade eligibility from the start.
Stringency in impurity and trace element limits sharply increases for any pharma or food-related synthesis. Regulatory status may trigger additional quality documentation—such as traceability, GMP status confirmation, or extended certificates of analysis. Industrial and pigment users generally weigh process compatibility over certification depth, unless finished goods pursue regulated markets.
Pigment, technical, and pharma grades differ by impurity spectrum, lot reproducibility, and analytical support. Higher grades demand more steps: specialized recrystallization, selective distillation, or advanced chromatographic techniques. Each route adjustment alters energy cost, throughput, or waste profile. Final impurity specification—both organic and inorganic—gets locked as a function of application risk and performance thresholds.
Run size and frequency of delivery set expectations for cost efficiency and production scheduling. Volume R&D buyers favor small, fast-turnaround lots, with close attention to analytical support. Bulk buyers, such as paint and pigment firms, prioritize predictable lead times and cost-to-value metrics but may waive stringent purity in favor of throughput. Balance always shifts between process economics and the application’s technical requirements.
Uncertainties over grade fit get resolved by trialing actual batch material in-process or in small-scale synthesis. We encourage downstream validation through sample lots, as in-process compatibility or side reaction profile can only be measured under customer-specific conditions. Manufacturer trial support includes full disclosure of the test methods applied, limits for key parameters, and technical advisory on any observed batch variability during scale-up.
Manufacturing 1-(2-Chlorophenyl)-3-methyl-5-pyrazolone draws on established quality management systems that have been implemented and maintained under rigorous internal and external audits. Production runs are supported by site-level certification frameworks such as ISO 9001 or other regionally recognized quality management standards, depending on the supply chain demands of the destination market. Regular re-certification audits focus on process compliance and traceability from raw material intake through final product release.
The certification approach for 1-(2-Chlorophenyl)-3-methyl-5-pyrazolone is inherently grade-specific. Downstream processing requirements—for example, pharmaceutical intermediates versus fine chemical uses—drive differences in impurity profiles, traceability, and documentation protocols. Certifications may include alignment with cGMP, REACH registration, or controlled batch validation reports for customers with regulated applications. Requests for product-specific statements such as BSE/TSE, allergen absence, or residual solvent declarations are handled via documentation rooted in batch history and analytical control.
Each batch is released with an internally validated Certificate of Analysis, reflecting final test results aligned with agreed specifications. Analytical methods and release limits are based on grade and end-use. Upon request, manufacturing can supply trace documentation, process flowcharts, and material safety data, subject to non-disclosure and regulatory boundary. Process change notifications are formalized and communicated to contracted partners with supporting rationale and impact analyses. Historical batch records are maintained and accessible under audit traceability protocols.
Demand for 1-(2-Chlorophenyl)-3-methyl-5-pyrazolone fluctuates across project timelines, especially for recurring sourcing in regulated sectors. Manufacturing relies on forecasting, modular scale-up options, and multi-line redundancy to manage volume swings without sacrificing batch consistency. For partners requiring guaranteed slots or just-in-time scheduling, supply agreements can be tailored with volume commitments, advance production planning, or consignment inventory, depending on contract structure.
Sustained output is achieved by controlling raw material qualification, maintaining buffer inventory, and running in-process parallel quality checks. Any constraint in upstream supply leads to adaptive sourcing strategies and multi-vendor qualification when permitted. Key control points—such as reagent purity, reaction temperature profiles, and solvent recovery—are monitored and logged to ensure repeatability. Output capacity is regularly reviewed against historic consumption and growth outlooks, and expansion projects are triggered by concrete order increments from anchor clients.
Sample provision follows a streamlined but strictly documented internal routing. Project teams evaluate sample requests based on grade, intended use, and regulatory context. Supplying samples to accredited labs or formulation teams involves documented batch release, small-scale fill, and COA inclusion; additional documentation (such as route of synthesis or impurity spectrum) can be arranged under technical disclosure or NDA, if project criteria demand deeper transparency.
No single business model addresses all cooperation needs in global chemical procurement. Manufacturers offer possibilities extending from spot purchase, make-to-order cycles, annual contract allotments, to framework agreements. Some customers benefit from flexible credit terms, bonded warehousing, or staged shipments to accommodate supply chain uncertainties. Priority production allocation and dynamic replanning become available for strategic partners with forecasted requirements or critical supply dependencies. The degree of flexibility is always a reflection of historic reliability, current negotiation, and operational feasibility.
In production environments, 1-(2-Chlorophenyl)-3-methyl-5-pyrazolone development pivots on synthesis route innovation, impurity management, and downstream integration. Research teams focus on achieving tighter impurity profiles and scalable crystallization methods. In real-time, optimization of catalyst systems and solvent choices attracts significant attention. For customers developing advanced intermediates or APIs, structural modification research drives interest—substituent tolerance, purity after workup, and batch-to-batch color stability represent key evaluation points. Analytical methods for residual solvents and chlorinated side-products are routinely scrutinized, especially for regulated markets.
Technical adoption patterns highlight the growing use of this pyrazolone derivative in pharmaceuticals—primarily as an intermediate for APIs marked by stringent regulatory review. Its structure supports further modifications, supporting demand in pigment synthesis and specialty chemicals. In R&D pilots for new dyes or agrochemical candidates, the need for custom impurity profiles and higher lot-to-lot reproducibility drives process improvements. Project feedback from industrial end-users feeds directly into formulation adjustments and post-synthesis downstream processing.
In manufacturing, the persistent challenge involves controlling chlorinated by-products and unreacted starting materials during scale-up. Process engineers implement staged purification and multi-point in-process control to reduce batch variability. Recent in-house breakthroughs rely on continuous flow technology and alternative raw material sourcing, supporting more consistent impurity profiles and lower cycle times. Efforts in real-time chromatography analytics minimize end-of-line rejection rates and accelerate troubleshooting.
Stability during extended storage and transport still depends on post-synthesis drying control and container headspace management, which requires routine adjustment as grade or end-use requirements shift.
Market direction follows pharmaceutical and pigment sector trends. In the next 3 to 5 years, producers anticipate a moderate rise in demand from bulk drug and specialty intermediate makers, tied to stricter regulatory thresholds for impurity limits. This raises requirements for analytical documentation and traceability across the supply chain. Regional shifts in outsourcing and custom synthesis contracts play a role, so multi-site production flexibility remains a high priority. Business intelligence points to steady double-digit growth in modified pyrazolone intermediates, especially for European and Asian regulatory markets.
Continuous flow synthesis and automation—already in early adoption in some plants—are set to become standard over the forecast period. Input traceability, digital batch management, and PAT-driven (Process Analytical Technology) systems are moving from pilot to full production settings. Industrial users supplying regulated markets expect transparent batch histories and vendor support for custom method validation.
In the last two years, R&D and production began shifting toward process steps with reduced chlorinated solvent use, solvent recycling, and waste minimization. Full LCAs (Life Cycle Assessments) are now included in several customer audits. Selection of process routes with greener footprints becomes a procurement criterion, influencing raw material contracts and in-plant process selection. As environmental scrutiny tightens, plants deploy water-neutral and closed-loop solvent handling where feasible, particularly for export-oriented production lines.
Technical teams actively engage with end-users to interpret application-specific analytical results and process outcomes. Consultation covers not only batch data interpretation but also interaction with customer QA for troubleshooting off-target results or unexplained color or impurity shifts. For new projects, custom analytical protocol development and raw material compatibility assessment are frequently requested.
Production engineers provide direct input during customer process integration, especially for scale-up or technology transfer scenarios. Support includes adjusting particle size distribution, solubility profiles, and impurity fingerprint strategies according to the specific downstream target—often after pre-shipment pilot sample feedback. In multi-stage synthesis or formulation, process modification suggestions are tailored case-by-case, as requirements for pigment, API, or specialty use will dictate acceptable property ranges.
Quality control and batch management teams address customer non-conformance reports with root-cause analysis based on batch records, in-process control charts, and retained sample comparisons. Change control processes empower technical support to review deviations against historic production parameters. Ongoing technical bulletins and stability guidance ensure customers receive up-to-date advice for optimal storage, handling, and formulation under varying climate or transport conditions.
Our facility produces 1-(2-Chlorophenyl)-3-methyl-5-pyrazolone from basic raw materials using continuous processes developed with an emphasis on process safety and throughput reliability. Each lot runs through a closed system designed to minimize contamination, safeguard consistent assay, and allow real-time adjustments based on in-process analytics. We control every reaction stage, from charge-in to final filtration and drying, so clients receive batches made under clear, monitored conditions.
This compound finds steady demand in pigment synthesis, chemical intermediates, and custom synthesis portfolios. Colorant sectors integrate it as a primary intermediate for high-performance azo pigments, as the molecule provides specific shades and thermal stability. Fine chemical producers employ it as a building block for specialty pyrazolone derivatives needed in crop protection, pharmaceuticals, or dye formulations. Our technical staff often assist clients in process adaptation, enabling reductions in solvent consumption or cycle time when scaling formulations that require this product’s performance attributes.
QA labs run batch analytics on every output lot. HPLC and GC profiles are established as benchmarks on our own reference standards, not third-party benchmarks. Analysts verify purity, identify trace byproducts, and set acceptance or rejection decisions. Any material departing our plant has been tracked from synthesis to bagging, documented by timestamped QC records. This reduces deviations between shipments and strengthens compliance with process validation requirements from our clients.
We supply this product in standard steel drums and high-barrier fiber containers, with inner PE lining for chemical stability and tight-sealing closures to prevent contamination. Our warehouse operates a finished-goods inventory buffer, which allows us to fill both scheduled and urgent replenishments for bulk and mid-sized users. Forklift-ready design and UN-compliant labelling streamline receiving and inventory control at the client’s facility, cutting unnecessary handling or repackaging steps.
Clients receive process documentation and technical support for integration into downstream manufacturing. Field engineers provide advice on filtration, dissolution, and blending, based on plant-scale trials and internal studies. If process issues arise, our production experts can review process deviations, supply impurity profiles, or recommend changes in kettle parameters or pH control to maximize value extraction from each delivery. Support extends to regulatory documentation and impurity statements for audit and compliance teams.
We understand production schedules and cost pressures. Predictable lead times and consistent product traits equip downstream manufacturers to reduce the risk of costly reformulation or downtime. Procurement professionals gain transparency and line-of-sight to batch traceability, reducing administrative effort during audits or supplier reviews. Distributors benefit by receiving containerized goods ready for direct dispatch, matched to market requirements for labeling, MSDS, and inventory systems.
We take responsibility for the chemistry behind each batch released and deliver solutions that help customers achieve stable output and regulatory peace of mind. Every consignment reflects operational discipline and decades of on-site process knowledge. Our reputation rests on the ability to solve concrete production challenges—and on a direct connection between our plant and your process lines.
Our experience manufacturing 1-(2-Chlorophenyl)-3-methyl-5-pyrazolone gives us a direct window into the key physicochemical properties that shape the handling, quality, and usability of this compound. Many researchers and formulators approach our technical team with questions about this molecule’s characteristics, especially as it relates to solid-state behavior and compatibility with other formulation ingredients.
During routine quality control, this compound consistently demonstrates a high degree of purity, which supports a melting range narrow enough for reliable downstream processing. A well-defined melting point stands as a primary indicator for quality reassurance, both for our internal validation and for customer acceptance testing. Our analytical batch records routinely confirm stability across standard melting point methods, preventing unexpected clumping, bridging, or polymorphic transitions during storage and shipping. This reliability smooths out production runs, as equipment calibration can depend on known phase changes, and ensures the finished product meets stringent pharmacopeial standards.
1-(2-Chlorophenyl)-3-methyl-5-pyrazolone exhibits limited solubility in aqueous solutions at room temperature, a trait rooted in its aromatic and pyrazolone system. This solubility profile controls how the product dissolves in different processing solvents. Our customers often signal this as a key point during technical reviews. Organic solvents such as ethanol, methanol, and acetonitrile show higher compatibility, facilitating faster dissolution rates. This matters during formulation, because partial solubilization not only impacts blend uniformity but also influences reaction kinetics when this compound acts as a starting material. Our team often helps customers select solvent systems compatible with both manufacturing scale and environmental controls, with precise solvent-candidate pairing shared during technical consultations.
Physical and chemical stability underpins both production and end-user reliability. This pyrazolone derivative maintains its structural integrity under dry, ambient storage. Our internal shelf-life studies—built from real-time samples under various controlled environments—confirm that the material remains stable in sealed packaging, without notable decomposition or color change. Moisture sensitivity remains low under recommended handling, so secondary protection against humidity becomes more about packaging logistics than inherent reactivity. This translates to predictable quality as the material moves across long-distance supply chains or stays in customer inventories for extended periods.
Batch reproducibility receives our primary focus at the synthesis and purification stages. Our production process, which relies on advanced synthetic techniques, ensures that purity, particle size, and phase composition all adhere to internal specification limits. This allows confident scale-up for customers developing downstream applications. If end-use requires modification in terms of particle size or packaging, our technical team can support customization requests to fit the operating envelope of specialized formulations and processing methods.
A deep understanding of melting point, solubility, and stability supports safe handling, high-yield processes, and seamless integration into both R&D and full-scale manufacturing environments. Our team stands ready to share data, offer technical guidance, and provide product tailored to meet both immediate and emerging needs in this active area of chemistry.
On the production floor, 1-(2-Chlorophenyl)-3-methyl-5-pyrazolone stands out as one of those specialty compounds that demands a tightly managed operation. Bulk chemical synthesis is never just about drums and reactors. Behind every kilogram lies real, daily balancing between raw material availability, equipment scheduling, and the safety practices required for handling chlorinated intermediates.
Our facility operates with batch reactors where efficiency depends on running each synthesis at a viable scale. The overhead of preparing, cleaning, and validating each run means the economics only work at a certain batch size. The usual minimum order for this material lines up with a single reactor charge—often 25 kg per batch. Smaller inquiries might seem feasible in a spreadsheet, but they disrupt the normal workflow and rarely make sense when factoring in both operation and analytical costs. Over the years, this scaling factor has proven ideal to keep both prices fair and lead times realistic for our customers. For those with recurring or annual requirements, volume commitments frequently enable better terms by optimizing demand forecasting and supply chain flow.
The minimum isn’t set arbitrarily. Hazardous waste disposal, cleaning protocols, and in-process analytical verification call for a disciplined approach. Running too small a batch generates disproportionate operational overhead and extends turnaround time. As manufacturers, aiming for this threshold supports both product consistency and safety obligations. Customers relying on our direct factory supply receive not just the finished compound—they benefit from the traceability and process controls that batch production at viable minimums provides.
Turnaround for 1-(2-Chlorophenyl)-3-methyl-5-pyrazolone depends on the existing production load and raw material lead times. Typically, our plant schedules this compound on a two to four-week cycle. This accounts for time needed to source high-purity precursors, prepare the reactor, complete synthesis, run full quality control, and package securely for transit. If upstream feedstocks are in good supply and the schedule is clear, we can sometimes fulfill standard orders in just under two weeks. Customers with specific purity or packaging needs should expect the higher end of the lead time range to allow for additional process steps or customized solutions.
Rush jobs enter a queue and pull from the same team and equipment as every other order. In the rare case of supply chain interruptions—seasonal logistics crunches, upstream shortages, or regulatory import procedures on raw materials—lead times stretch accordingly. Experience in dealing with global logistics partners pays off here; we’ve learned to buffer raw material inventory and keep alternative routes on standby. The goal always revolves around minimizing downtime and keeping communication clear if unavoidable delays emerge.
Careful planning on both sides brings real advantages. Bulk synthesis of 1-(2-Chlorophenyl)-3-methyl-5-pyrazolone benefits from early forecasts and clear usage projections. Over-ordering leads to unnecessary inventory holding costs and waste. Last-minute, small-quantity orders tend to disrupt manufacturing schedules and drive up cost per unit. Our technical team provides guidance to clients outlining the rhythm of batch cycles, best order sizes for cost efficiency, and the value of consolidated purchasing when possible. In our experience, collaboration achieves shorter lead times and helps customers secure material ready for their own production windows, which can be critical in pharmaceutical and agrochemical segments.
Supplying directly from our factory means customers access genuine process history, real-time updates during production, and immediate access to technical support. We welcome requests for analytical data, packing options, or minor adjustments to specifications. The connection between customer operations and our own batch lineup drives real value—something that can’t be matched by disconnected intermediaries or generalist distributors.
At our production facilities, we handle 1-(2-Chlorophenyl)-3-methyl-5-pyrazolone from raw material sourcing all the way through to dispatch. Regulations and documentation in transportation and storage are not just box-ticking exercises for us. Our direct responsibility starts at synthesis and covers every step until the product reaches our customers’ warehouses or laboratories. This chemical, widely used as an intermediate in fine chemicals and pharmaceuticals, arrives at our loading docks under close scrutiny: legal, technical, and safety expectations guide every part of our process.
We do not move a gram of 1-(2-Chlorophenyl)-3-methyl-5-pyrazolone without the required paperwork. Our shipments always include a Safety Data Sheet in line with GHS, with updated hazard communication elements. The custom authorities require us to submit this documentation, and our logistics partners expect it to accompany the cargo. This is not just formalism. It ensures that everyone across the supply chain—drivers, warehouse staff, and end-users—receives the right safety protocols.
Staying within chemical sector standards, our packages come clearly labeled according to national and international transport regulations. We only use containers tested for chemical compatibility. Labels reflect accurate hazard class, UN numbers, and handling instructions in accordance with the relevant regulations such as ADR/RID or IMDG, depending on the transport route. Our technical team regularly reviews transport laws—changes to regulations or new guidance from authorities are implemented promptly in our process documentation and logistics workflow.
Storage at our facility follows strict protocols informed by the latest safety data. Since 1-(2-Chlorophenyl)-3-methyl-5-pyrazolone is not classified as highly flammable or at risk of spontaneous decomposition, it does not fall under major hazard storage thresholds. Still, we segregate it from incompatible substances and keep the storage climate within recommended temperature and humidity ranges to preserve material integrity and minimize risk of contamination or degradation.
Our warehouses feature automated environmental controls and routine inspections. Before dispatch, we verify the physical and chemical stability of each lot. Access to our storage area relies on trained and authorized personnel. Our health and safety officers document every movement and handling step in compliance logs, which remain available for regulatory audits or customer queries. Storage duration is managed according to our internal shelf-life data, and we conduct regular stock reviews to ensure first-in, first-out inventory rotation.
Regulation in chemical transport is continually evolving. Sometimes, requirements vary at the state or border level. Our compliance experts participate in industry forums to gather insights on pending changes before they take effect. Certification processes can slow down shipments, so we keep our documentation and product testing up to date well ahead of transport schedules.
Ensuring traceability is central to our approach. Each batch is assigned a unique lot number, allowing us and our customers complete visibility into origin, production record, and chain of custody. This traceability supports fast response should any incident or question arise.
Our involvement doesn’t end when the product leaves our site. We engage directly with our transportation partners to confirm secure loading practices and document verification. Our customer service and technical support teams stand ready to provide any further compliance materials, guidance on local regulations, or additional documentation required by end users, authorities, or auditors. By handling these responsibilities directly and transparently, we safeguard both product quality and everyone who interacts with it along the supply chain.
For product inquiries, sample requests, quotations or after-sales support, please feel free to contact me directly via sales7@bouling-chem.com, +8615371019725 or WhatsApp: +8615371019725
